Real-world treatment patterns and outcomes in refractory metastatic colorectal cancer.

CONCLUSION: Active 3L and beyond treatment significantly prolonged OS versus palliative care, even in selected "trial ineligible" patients. Given a high rate of palliation only care in eligible patients, improved patient access to medicine and counseling may be needed to maximize outcomes.
PMID: 30887726 [PubMed - as supplied by publisher]

Source: Clinical Colorectal Cancer - March 18, 2019 Category: Cancer & Oncology Authors: Chiang CL, Choi HC, Lam KO, Chan BY, Lee SF, Yeung SY, Lau KS, Chan SY, Choy TS, Yuen KK Tags: Asia Pac J Clin Oncol Source Type: research